Status:
COMPLETED
Evaluation of the Relationship Between Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women
Lead Sponsor:
Kanuni Sultan Suleyman Training and Research Hospital
Collaborating Sponsors:
Ayşegül Bestel
İbrahim Polat
Conditions:
COVID
Zinc Deficiency
Eligibility:
FEMALE
18-45 years
Brief Summary
Zinc d vitamin and b12 serum levels in covid-19 positive pregnants will be compared in terms of patients' responses to computed tomography and treatment.
Detailed Description
Serum zinc, vitamin d vitamin b12 levels of 45 patients will be measured and evaluated together with the information of the patients.
Eligibility Criteria
Inclusion
- covid-19 positive pregnant women
- under 18 or more than 45 years old
Exclusion
- vitamin D , Vitamin B12 or Zinc supplement use
- Multivitamine use
- have taken vitamin supplements in the past 3 months
- use of medicines for vitamin deficiency
- having metabolic disease covid-19 negative pregnant women
Key Trial Info
Start Date :
April 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 14 2020
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04407572
Start Date
April 20 2020
End Date
June 14 2020
Last Update
June 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pinar Yalcin Bahat
Istanbul, İ̇stanbul, Turkey (Türkiye), 34000